CID 216237

Tolvaptan

Structural Information

Molecular Formula
C26H25ClN2O3
SMILES
CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C
InChI
InChI=1S/C26H25ClN2O3/c1-16-6-3-4-7-20(16)25(31)28-19-10-11-21(17(2)14-19)26(32)29-13-5-8-24(30)22-15-18(27)9-12-23(22)29/h3-4,6-7,9-12,14-15,24,30H,5,8,13H2,1-2H3,(H,28,31)
InChIKey
GYHCTFXIZSNGJT-UHFFFAOYSA-N
Compound name
N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide
Related CIDs

2D Structure

compound 2d structure
7
Annotation Hits

1148
References

4750
Patents

448.15536 Da
Monoisotopic Mass

4.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 449.16264 209.5
[M+Na]+ 471.14458 222.4
[M+NH4]+ 466.18918 215.6
[M+K]+ 487.11852 215.2
[M-H]- 447.14808 214.9
[M+Na-2H]- 469.13003 215.9
[M]+ 448.15481 213.2
[M]- 448.15591 213.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe